Znclue Pharma Private Limited
About Znclue Pharma Private Limited
Data last updated:
Znclue Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 27 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC309765. Its GSTIN is 06AABCZ0325P1Z5 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Jagdish Kumar and Rahul Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 23 1st Floor Ring Road Rajouri Garden, New Delhi, Delhi, India – 110027.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.23 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹4,720 (net margin 0.4%) and EBITDA of ₹23,912 (EBITDA margin 2.1%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 23 1st Floor Ring Road Rajouri Garden, New Delhi, Delhi, India – 110027
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Znclue Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Znclue Pharma Private Limited
FY 2025 filings availableZnclue Pharma Private Limited reported revenue of ₹11.23 Lakh (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 29% over five years, including a 18% fall in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹23,912 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹4,720 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.1% | |
| Net Profit Margin | 0.4% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Znclue Pharma are in the company report.
: available in the company report
Board of Directors of Znclue Pharma Private Limited
Znclue Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdish Kumar | Director | 27 Dec 2016 | 9 Years 9 Months | Current |
| Rahul Bansal | Director | 27 Dec 2016 | 9 Years 9 Months | Current |
Peer Comparison
Znclue Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prakshit Technologies Private Limited | ₹11.23 Lakh (FY 2022) | •••• | •••• | 0.0% | •••• | Patna, Bihar, India |
| Eddys Coffee Private Limited | ₹11.23 Lakh (FY 2024) | •••• | •••• | 2855.0% | •••• | Kolkata, West Bengal, India |
| Brugen Pharmaceuticals Private Limited | ₹11.23 Lakh (FY 2025) | •••• | •••• | 88.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Fview International Private Limited | ₹11.23 Lakh (FY 2022) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Saidatta Farmers Producer Company Limited | ₹11.23 Lakh (FY 2023) | •••• | •••• | •••• | Osmanabad, Maharashtra, India | |
| Znclue Pharma Private Limited this company | ₹11.23 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | New Delhi, Delhi, India |
| Ashr Datatech Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 525.0% | •••• | Chennai, Tamil Nadu, India |
| Hartex International Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
| Apray Pharma Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Meerut, Uttar Pradesh, India |
| Epikart Pharma Private Limited | ₹11.22 Lakh (FY 2024) | •••• | •••• | 120.0% | •••• | Bangalore, Karnataka, India |
| Staylife Pharma Private Limited | ₹11.22 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India |
Peers are the companies nearest to Znclue Pharma by revenue, above and below it, in the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Znclue Pharma Private Limited is audited by ARVIND JAIN for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARVIND JAIN | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Znclue Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Znclue Pharma.
: available in the company report
Recent Activity
Znclue Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Jagdish Kumar was appointed as Director on 27 Dec 2016.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Znclue Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCZ0325P1Z5 | Haryana | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Znclue Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 27 December 2016 (10+ years old) and is registered under CIN U74999DL2016PTC309765.
Znclue Pharma has 2 current directors:
- Jagdish Kumar - Director
- Rahul Bansal - Director
The latest financial statements of Znclue Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Znclue Pharma is 06AABCZ0325P1Z5, registered in Haryana.
The CIN (Corporate Identification Number) of Znclue Pharma is U74999DL2016PTC309765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Znclue Pharma was incorporated on 27 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Znclue Pharma by revenue are Prakshit Technologies Private Limited, Eddys Coffee Private Limited, Brugen Pharmaceuticals Private Limited, Fview International Private Limited, Saidatta Farmers Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Jagdish Kumar was appointed as Director on 27 Dec 2016. Rahul Bansal was appointed as Director on 27 Dec 2016.
The registered office of Znclue Pharma is at A – 23 1st Floor Ring Road Rajouri Garden, New Delhi, Delhi, India – 110027.
Znclue Pharma operates in the business services industry, in the other services segment.
The compliance status of Znclue Pharma is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.